1. Market Research
  2. > Pharmaceutical Market Trends
  3. > OTC

OTC (Over-the-Counter) Drug Industry Research, Data, Statistics & Trends

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
23 votes

Topics under OTC

Global Over-The-Counter Drug Industry

OTC medicines are drugs for which no prescription is necessary. They are sold in pharmacies or other retail outlets and are used in the prevention and treatment of relatively minor ailments such as headaches and heartburn. These kinds of drugs are not necessarily dispensed by professionals with medical knowledge, though they can have side effects or interfere with other medicines. Restricted OTC substances are generally sold in outlets employing a registered pharmacist.

Over-the-counter drug industry statistics show that this kind of medicines is the first port of call for physicians and patients alike in the treatment of minor ailments, with close to 90% of medical care providers recommending patients self-treat minor conditions and the vast majority of patients taking this option. OTC upper respiratory infection medications represent savings of more than $4.5 billion a year for the US healthcare system, while OTC medications to treat heartburn mean savings of close to $760 million annually, or almost $175 per person, reports the Consumer Healthcare Products Association. 

Over the Counter Drug Regulations

The regulatory body for OTC products in the US is the Food and Drug Administration (FDA). Despite regulations on OTC medicines, their responsible use remains a concern. The government takes some legislative measures to try to prevent the abuse of these medicines. Cough medicine containing dextromethorphan (DXM) have been widely abused by teenagers in the US, prompting a State Senator to enact legislation restricting the sale of cough medicine containing DXM to minors.

Medicines sold as prescription drugs can be cleared for sale as OTC medicines, granting greater accessibility to consumers. The switchover segment of the market is to show substantial growth. To comply with OTC status requirements, a medicine must be safe, effective and well labeled to provide consumers with comprehensive information about the treatment and its possible side effects. The Consumer Healthcare Products Association reports over 700 over the counter products on sale today contain ingredients or dosages that necessitated a prescription less than three decades ago.

Best-Selling OTC Drugs

Cough and cold medicines constitute the top selling OTC medicine for sale on the US market. Painkillers are the second-biggest seller. Heartburn medicines were in third place. Other popular OTC products include laxatives, oral antiseptics, and rinses, first aid care, sunscreen and contact lens products.

Topical OTC drugs are another important market segment. Antiseptic cleansers account for the largest part of the topical OTC medicines market at almost 60%, with anti-itch products in second place at almost 28%, followed by anesthetic products, which represent more than 10% of the segment.

OTC Drug Industry Leaders

Novartis is a world leader in the OTC products industry. The company employs more than 115,000 people across 140 countries, with almost half of them working in the EU. Its extensive OTC product portfolio includes Bufferin and Excedrin used in pain management, anti-inflammatory Volterin, fiber supplements Pursennid and Benefiber. Its cough/cold products include Buckley’s, Comtrex, and Sinecod along with sore throat treatments Lemocin, Mebucaine, and Orofar. Novartis sells respiratory products Otrivin, Rhinomer, and 4-Way for the treatment of nasal congestion.

Read more »

Share
24/7 Customer Support

Talk to Sam

+44 208 068 8943

1-10 of about 6100 reports

Global OTC Industry - Forecast

  • June 2017
    6 pages
  • OTC  

  • United States  

    World  

View report >

OTC Industry in Nigeria and the US - Forecast, Weekly Update

  • November 2017
    5 pages
  • OTC  

  • Nigeria  

    United States  

    Africa  

View report >

OTC Industry in Europe - Forecast

  • September 2017
    160 pages
  • Europe  

View report >

OTC Markets in Japan and Asia

  • December 2015
    22 pages
  • OTC  

  • Japan  

    Asia  

    India  

View report >

OTC Markets in Japan

  • December 2016
    23 pages
  • OTC  

  • Japan  

    Asia  

    China  

View report >

OTC Industry in France

  • January 2017
    17 pages
  • OTC  

  • France  

View report >

OTC Markets in Europe and Germany

  • June 2017
    24 pages
  • OTC  

    OTC  

  • Europe  

View report >

OTC Industry in Italy

  • January 2017
    10 pages
  • OTC  

  • Italy  

    Europe  

View report >

OTC Markets in the UK

  • October 2017
    6 pages
  • OTC  

  • United Kingdom  

View report >

OTC Markets in Canada

  • August 2017
    8 pages
  • OTC  

  • Canada  

    North America  

View report >


About 4700 reports

Purchase Reports From Reputable Market Research Publishers
(From € 115 - € 20000)

Women's Health Rehabilitation Products Industry: Forecasts to 2024

  • € 5268
  • Industry report
  • July 2016
  • by Transparency Market Research

This report on the women’s health rehabilitation products market analyzes the current as well as future prospects of the market globally. Rehabilitation programs include exercise training, monitoring ...

Weight Loss and Weight Management Market: Global Foreca ...

October 2017 € 5045

Health Ingredients Market: Global forecast until 2022

August 2017 € 5045

Topical Drug Delivery Market: Global Forecast until 202 ...

March 2017 € 5045

Industrial Alcohol Market: Global Forecast until 2022

February 2017 € 5045

U.S. Insomnia Market: Forecasts until 2021

January 2017 € 5045

Animal Antibiotics and Antimicrobials Market: Global Fo ...

December 2016 € 5045

Prebiotic Ingredients Market: Global Forecast until 202 ...

November 2016 € 5045

Asia-Pacific Animal Health Market: Forecast until 2021

October 2016 € 5045

Cold Pain Therapy Market: Forecast until 2021

October 2016 € 5045

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.